nocodazole has been researched along with Atherosclerotic Parkinsonism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fanara, P | 1 |
| Wong, PY | 1 |
| Husted, KH | 1 |
| Liu, S | 1 |
| Liu, VM | 1 |
| Kohlstaedt, LA | 1 |
| Riiff, T | 1 |
| Protasio, JC | 1 |
| Boban, D | 1 |
| Killion, S | 1 |
| Killian, M | 1 |
| Epling, L | 1 |
| Sinclair, E | 1 |
| Peterson, J | 1 |
| Price, RW | 1 |
| Cabin, DE | 1 |
| Nussbaum, RL | 1 |
| Brühmann, J | 1 |
| Brandt, R | 1 |
| Christine, CW | 1 |
| Aminoff, MJ | 1 |
| Hellerstein, MK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Proof-of-Concept Clinical Research Study of Efavirenz in Patients With Alzheimer's Disease[NCT03706885] | Phase 1 | 5 participants (Actual) | Interventional | 2018-05-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for nocodazole and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Amyloid beta-Protein Precursor; Anima | 2012 |